You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Th17

Showing 26 - 50 of 7,983
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SARS-CoV-2, Influenza, RSV Trial in Australia, United Kingdom, United States (mRNA-1010, mRNA-1345, mRNA-1273.214)

Recruiting
  • SARS-CoV-2
  • +2 more
  • mRNA-1010
  • +4 more
  • DeLand, Florida
  • +29 more
Jan 23, 2023

Lymphocyte Subsets of Peripheral Blood in Nonmyopathic

Recruiting
  • Dermatomyositis
    • Jinan, Shandong, China
      Yanfeng Hou
    Nov 19, 2023

    Hypertension Trial in United Kingdom (Amlodipine, Lisinopril, Amiloride)

    Recruiting
    • Hypertension
    • Cambridge, Cambridgeshire, United Kingdom
    • +13 more
    Jul 27, 2021

    Advanced Multiple Sclerosis, Progressive Multiple Sclerosis Trial in United Kingdom (Cladribine (MAVENCLAD®), Placebo)

    Recruiting
    • Advanced Multiple Sclerosis
    • Progressive Multiple Sclerosis
    • Cladribine (MAVENCLAD®)
    • Placebo
    • Belfast, United Kingdom
    • +18 more
    Jun 9, 2022

    Melanoma (Skin) Trial in Nice, Montpellier, Lille (Evaluation of cytokine production)

    Not yet recruiting
    • Melanoma (Skin)
    • Evaluation of cytokine production
    • Nice, Alpes-maritimes, France
    • +2 more
    Dec 5, 2022

    COVID-19 Outbreak Consequences for Outpatients Followed in PRM

    Completed
    • Chronic Disabling
    • COVID-19
      • Montpellier, France
        Uh Montpellier
      May 20, 2020

      Host Microbiota and Il-17 in Favoring Multiple Myeloma

      Recruiting
      • Multiple Myeloma
        • Milan, Milano, Italy
          IRCCS Ospedale San Raffaele
        Jan 26, 2023

        Allergic Rhinitis Trial in Anshan (Dust mite drops (trade name: Changdi, Zhejiang Tawu Biotechnology Co. Ltd.).)

        Not yet recruiting
        • Allergic Rhinitis
        • Dust mite drops (trade name: Changdi, Zhejiang Tawu Biotechnology Co. Ltd.).
        • Anshan, Guizhou, China
          Guangjun Tang
        Oct 5, 2022

        Trauma Injury Trial in United Kingdom, United States (Cryoprecipitate, Red Blood Cells, Plasma)

        Active, not recruiting
        • Trauma Injury
        • Cryoprecipitate
        • +4 more
        • Houston, Texas
        • +24 more
        Jan 13, 2022

        SARS-CoV-2 Trial in United Kingdom (mRNA-1273.529, mRNA-1273, mRNA-1273.214)

        Recruiting
        • SARS-CoV-2
        • mRNA-1273.529
        • +2 more
        • Aberdeen, Aberdeenshire, United Kingdom
        • +28 more
        Apr 11, 2022

        Global, Multicentre, Non Interventional Advagraf Conversion

        Completed
        • Kidney Transplantation
        • Camperdown, New South Wales, Australia
        • +128 more
        Nov 10, 2022

        Osteogenesis Imperfecta Trial in Worldwide (Denosumab)

        Completed
        • Osteogenesis Imperfecta
        • Los Angeles, California
        • +48 more
        Apr 1, 2022

        Axial Spondyloarthritis (axSpA), Ankylosing Spondylitis (AS) Trial in Marseille (blood samples)

        Completed
        • Axial Spondyloarthritis (axSpA)
        • Ankylosing Spondylitis (AS)
        • blood samples
        • Marseille, France
          Assistance Publique Hopitaux de Marseille
        Aug 31, 2022

        Axial Spondyloarthritis, Psoriatic Arthritis Trial in Istanbul (serum raftlin-1 protein levels)

        Recruiting
        • Axial Spondyloarthritis
        • Psoriatic Arthritis
        • serum raftlin-1 protein levels
        • Istanbul, Turkey
          Bezmialem University
        Mar 22, 2023

        Covid19 Trial in Worldwide (C21, Placebo)

        Completed
        • Covid19
        • Orange, California
        • +60 more
        Sep 8, 2022

        Repeated Embryo Implantation Failure, Recurrent Miscarriage, Immune System Trial in Amiens (blood sample)

        Recruiting
        • Repeated Embryo Implantation Failure
        • +2 more
        • blood sample
        • Amiens, Picardie, France
          Centre Hospitalier Universitaire d'Amiens
        Dec 5, 2022

        Tuberous Sclerosis Complex Trial in United States (Basimglurant with crossover to Placebo, Placebo with crossover to

        Recruiting
        • Tuberous Sclerosis Complex
        • Basimglurant with crossover to Placebo
        • Placebo with crossover to Basimglurant
        • Phoenix, Arizona
        • +47 more
        Jan 3, 2023

        Implication of 5-HT7 Receptor in Inflammatory Mechanisms in

        Not yet recruiting
        • Healthy
        • Multiple Sclerosis
        • Blood sample
        • Orléans, France
          CHR Orléans
        Feb 16, 2023

        TH17 Lymphocytes in Horton's Disease (HD)

        Completed
        • Horton's Disease
        • +4 more
        • 1 blood sample
        • 2 to 3 blood samples (at inclusion, at 3 months and at 6 months in cases of relapse)
        • Besancon, France
        • +2 more
        May 3, 2019

        Cytomegalovirus Infection Trial in United Kingdom, United States (Placebo, Valganciclovir)

        Completed
        Has Results
        • Cytomegalovirus Infection
        • Birmingham, Alabama
        • +17 more
        May 6, 2021

        Sepsis, Immune System Disorder, Enteral Feeding Trial in Nanjing (enteral nutrition)

        Completed
        • Sepsis
        • +2 more
        • enteral nutrition
        • Nanjing, Jiangsu, China
          Nanjing First Hospital
        Mar 2, 2019

        HIV I Infection, Tuberculosis Trial in South Africa (MTBVAC, BCG)

        Not yet recruiting
        • HIV I Infection
        • Tuberculosis
        • MTBVAC
        • BCG
        • Westdene, Gauteng,, South Africa
        • +15 more
        Jul 21, 2023

        Psoriasis and Non Alcoholic Steatohepatitis: Is ThereShared

        Not yet recruiting
        • Nash
          • (no location specified)
          Aug 15, 2023

          Breast Feeding, Exclusive Trial in Trabzon (Providing breastfeeding support with Telehealth)

          Completed
          • Breast Feeding, Exclusive
          • Providing breastfeeding support with Telehealth
          • Trabzon, Turkey
            University
          Jul 6, 2023

          Generalized Myasthenia Gravis Trial in Worldwide (ARGX-113, Placebo)

          Completed
          Has Results
          • Generalized Myasthenia Gravis
          • ARGX-113
          • Placebo
          • Phoenix, Arizona
          • +65 more
          Jan 14, 2022